2026 NPPES data Critical Care Medicine (Internal Medicine) Physician NPI 1952330300 M.D., FCCP
Verify on CMS →

MARK LUND, M.D., FCCP

Critical Care Medicine (Internal Medicine) Physician in PHILADELPHIA, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
273
Medicare Part D claims · 70 beneficiaries · Critical Care Medicine (Internal Medicine) Physician avg: 1K
Generic prescribing
41%
generic claims · 59% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$42.74
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK LUND, M.D., FCCP filed 273 Medicare Part D claims in 2023 as a Critical Care Medicine (Internal Medicine) Physician in PHILADELPHIA, Pennsylvania, prescribing 41% generic.

273
Part D claims, 2023
41%
generic prescribing
$42.74
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK LUND, M.D., FCCP's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

273 49th percentile higher than 49% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

MARK LUND, M.D., FCCP practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK LUND, M.D., FCCP?

Quality data not reported

NPI registry status

Active

Issued 06/30/2006

NPI 1952330300

Primary specialty

Critical Care Medicine (Internal Medicine) Physician

Mid-sized

6,631 US NPIs in this specialty

Medicare Part D claims

273 74% vs specialty avg

2023 prescription claims

Specialty avg: 1,069

Specialty distribution in Pennsylvania

How Critical Care Medicine (Internal Medicine) Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Critical Care Medicine (Internal Medicine) Physician share within Pennsylvania

1. Critical Care Medicine (Internal Medicine) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Critical Care Medicine (Internal Medicine) Physician share within Pennsylvania

Specialty board-certification context

Estimated specialty board-certified rate — Critical Care Medicine (Internal Medicine) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Critical Care Medicine (Internal Medicine) Physician ABMS/AOA estimate

Est. board-certified rate (Critical Care Medicine (Internal Medicine) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Critical Care Medicine (Internal Medicine) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK LUND, M.D., FCCP appears in the CMS NPPES registry as a Critical Care Medicine (Internal Medicine) Physician provider holding M.D., FCCP credentials at 1331 E WYOMING AVE, PHILADELPHIA, PA, 19124, with a listed phone of (215) 537-7400. NPI 1952330300 was issued on 06/30/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LUND most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 273 prescription claims written by this provider, covering 70 Medicare beneficiaries and totaling roughly $96K in drug spend, split 59% brand-name and 41% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Critical Care Medicine (Internal Medicine) Physician is a mid-sized specialty nationwide, with 6,631 enrolled providers across 53 states and an average of 1,069 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1331 E WYOMING AVE
PHILADELPHIA, PA 19124

Provider Details

NPI 1952330300
Specialty Critical Care Medicine (Internal Medicine) Physician
Credentials M.D., FCCP
Gender Male
NPI Issued 06/30/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK LUND, M.D., FCCP. Source: openpaymentsdata.cms.gov.

Total received

$43

Largest payer

Insmed, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to MARK LUND, M.D., FCCP. To verify MARK LUND, M.D., FCCP's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

MARK LUND, M.D., FCCP — brand share 59.0%
Specialty average (est.)

59% brand-name claims vs 41% generic, on 273 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

273
Total Claims
$96K
Total Drug Cost
70
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
316
Total Day Supply
8,286
Brand vs Generic
59% brand / 41% generic
Brand Drug Cost
$93K
Generic Drug Cost
$3K
Antibiotic Claims
46

Patient Demographics

Average Patient Age
74.2 years
Avg HCC Risk Score
1.91
Gender Split
60% female / 40% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK LUND, M.D., FCCP prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
64
Prednisone
29
Azithromycin
25
Albuterol Sulfate Hfa
Albuterol Sulfate
19
Anoro Ellipta
Umeclidinium Brm/Vilanterol Tr
19
Stiolto Respimat
Tiotropium Br/Olodaterol Hcl
16
Symbicort
Budesonide/Formoterol Fumarate
16
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
13
Montelukast Sodium
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Critical Care Medicine (Internal Medicine) Physician Overview

How MARK LUND, M.D., FCCP fits within the Critical Care Medicine (Internal Medicine) Physician landscape nationally.

6,631
Critical Care Medicine (Internal Medicine) Physician Providers in US
53
States with Critical Care Medicine (Internal Medicine) Physician
1,069
Avg Claims per Provider

MARK LUND, M.D., FCCP's 273 claims are below the specialty average of 1,069.

Nearby Critical Care Medicine (Internal Medicine) Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as LUND.

Compare Critical Care Medicine (Internal Medicine) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK LUND, M.D., FCCP's specialty?
MARK LUND, M.D., FCCP specializes in Critical Care Medicine (Internal Medicine) Physician and practices in PHILADELPHIA, Pennsylvania. Credentials: M.D., FCCP.
How much does MARK LUND, M.D., FCCP prescribe under Medicare Part D?
In 2023, MARK LUND, M.D., FCCP wrote 273 Medicare Part D claims totaling $96K in drug costs for 70 beneficiaries.
Where is MARK LUND, M.D., FCCP located?
MARK LUND, M.D., FCCP is located at 1331 E WYOMING AVE, PHILADELPHIA, PA, 19124. Phone: (215) 537-7400.
What is MARK LUND, M.D., FCCP's NPI number?
MARK LUND, M.D., FCCP's National Provider Identifier (NPI) is 1952330300, issued on 06/30/2006.
Does MARK LUND, M.D., FCCP prescribe more brand-name or generic drugs?
MARK LUND, M.D., FCCP's prescribing is 59% brand-name and 41% generic drugs by claim count, with $93K in brand drug costs.
How many Critical Care Medicine (Internal Medicine) Physician providers are there in the US?
There are 6,631 Critical Care Medicine (Internal Medicine) Physician providers across 53 states in the US. The average Critical Care Medicine (Internal Medicine) Physician provider writes 1,069 Medicare Part D claims per year.
What drugs does MARK LUND, M.D., FCCP prescribe most often?
Based on 2023 Medicare Part D data, MARK LUND, M.D., FCCP's most frequently prescribed drugs include Trelegy Ellipta, Prednisone, Azithromycin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK LUND, M.D., FCCP accept Medicare?
MARK LUND, M.D., FCCP appears in CMS Medicare data with 273 Part D claims and 70 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK LUND, M.D., FCCP's credentials?
MARK LUND, M.D., FCCP's NPI is 1952330300 with credentials M.D., FCCP. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology